First Manhattan’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.89M Buy
1,536,575
+2,250
+0.1% +$5.76K 0.01% 274
2025
Q4
$5.12M Buy
1,534,325
+84,675
+6% +$301K 0.01% 230
2025
Q3
$5.55M Hold
1,449,650
0.01% 228
2025
Q2
$6.23M Buy
1,449,650
+83,964
+6% +$338K 0.02% 202
2025
Q1
$5.37M Buy
1,365,686
+8,061
+0.6% +$38.2K 0.02% 208
2024
Q4
$6.9M Sell
1,357,625
-13,175
-1% -$75.9K 0.02% 179
2024
Q3
$9.73M Buy
1,370,800
+313,550
+30% +$2M 0.03% 146
2024
Q2
$6.02M Buy
1,057,250
+183,875
+21% +$1.17M 0.02% 191
2024
Q1
$6.49M Buy
873,375
+177,175
+25% +$1.48M 0.02% 185
2023
Q4
$6.45M Buy
+696,200
New +$5.14M 0.02% 189

Other funds holding CLVT

First Manhattan's CLVT Position: Q1 2026 in Review

First Manhattan increased its Clarivate (CLVT) stake by 0.15% in Q1 2026, buying an estimated $5.76K and bringing the position to 1,536,575 shares worth $3.89M. The position accounts for 0.01% of the portfolio, ranked #274.

First Manhattan first reported a position in CLVT in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.73M in Q3 2024. 254 funds tracked by Wall St. Rank hold CLVT as of Q1 2026.

  • First Manhattan held 1,536,575 shares of Clarivate worth $3.89M as of Q1 2026.
  • First Manhattan bought 2,250 Clarivate shares in Q1 2026, an estimated $5.76K.
  • Clarivate made up 0.01% of First Manhattan's portfolio in Q1 2026, its #274 holding.
  • First Manhattan first reported a position in Clarivate in Q4 2023 and has held it in 10 quarters since.
  • First Manhattan's Clarivate position peaked at $9.73M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Clarivate as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.